Hantgo.com

Stay Informed Stay Ahead

    • Medicine

    Vetter marks the start of clinical site construction

    admin Posted on

    Vetter, a global Contract Development and Manufacturing Organisation (CDMO), celebrated the start of construction for its new clinical manufacturing site in Des Plaines with an official groundbreaking ceremony on 26th June.

    The independent pharmaceutical service provider received the building permit for the new site in April of this year. With an investment of approximately $285 million, this new facility underscores Vetter’s dedication to delivering high-quality services and drug products during early clinical development.

    “In the current economic climate, it is a positive sign to see an international company like Vetter making a significant investment to expand their footprint here in the Chicago suburbs,” said Des Plaines Mayor Andrew Goczkowski. “This new facility will create high-quality jobs for our residents and bolster our local economy. We are excited to welcome Vetter as a valued member of our Des Plaines community.”

    Upstream and ground preparation work on the premises started back in April. Vetter’s construction plans include a 160,000 square feet clinical production facility for aseptic manufacturing. The site will also feature new process areas for material preparation and compounding. Additional buildings will include supporting services like storage, laboratories, and offices. The clinical site is expected to be completed and ready for media fill by the end of 2029, with subsequent relocation plans of Vetter’s current clinical operations in Skokie.

    “Today’s groundbreaking ceremony marks another significant milestone within our continuing expansion plans,” said Senator h.c. Udo J. Vetter, chairman of the Advisory Board and member of the owner family. “The new site will not only demonstrate our enhanced clinical operations and manufacturing capabilities but will also expand our presence in the U.S. significantly. We want to express our deep gratitude for the warm hospitality of the Illinois Science + Technology Park since 2009, hosting and supporting our successful start of U.S. manufacturing operations. We are excited to now be able to officially kick off this ambitious project.”

    Vetter representatives, along with city officials from Des Plaines and other guests, gathered for the groundbreaking ceremony, marking the next phase of Vetter’s growing footprint in the U.S. The event featured speeches highlighting the plans for the facility and its role within Vetter’s global network of drug manufacturing operations.

    LEAVE A RESPONSE

    Your email address will not be published. Required fields are marked *

    admin
    View all posts

    You Might Also Like

    Medicine

    Aramex Scoop Sustainability AwardGlobal logistics giant Aramex has been awarded the Sustainability in Distribution award at the recent Distributing Pharmaceuticals UK award event at the Coventry Building Society Arena. The awards night recognised the very best in innovation and sustainability from those that are directly involved in the design, development or distribution of pharmaceuticals – a sector in which Aramex has a significant footprint. Despite being up against fierce competition within their selected category, the judges ruled that Aramex’s unwavering commitment to sustainability, environmental stewardship, and mitigating climate risks were what tipped the scales on the night. Citing a 42% reduction based on scope 1 & 2 and a 25% reduction on scope 3, dependent on supplier commitment, Aramex has since 2006 implemented a multifaceted climate change mitigation strategy with the sole aim of minimising its carbon footprint and improving its impact on the environment. This strategy involves investment into renewable energy projects, commitment to minimising waste and promoting recycling across its network, enhancing energy efficiency across its operations, with initiatives such as ISO 14001 certification, LEED certification for its facilities along with further energy efficiency projects to drive down usage. Reduced water consumption, route optimisation projects to reduce fuel consumption and emissions, and a commitment to gradually transitioning its fleet to electric and low-emission vehicles have also been put in place. Aramex has also implemented its Future Vehicle Program which explores innovative solutions such as autonomous vehicles and drone deliveries to enhance efficiency and reduce environmental impact in the years to come. Ronan Kitchin who heads up the Life Science and Healthcare division at Aramex UK commented: “We are delighted to have been recognised by Distributing Pharmaceuticals at their recent award event for our work in driving sustainability initiatives throughout our distribution services – a commitment which we have made significant strides towards over the past two decades. “With a legacy of championing sustainability, our environmental and climate change mitigation strategy looks to deliver tangible and positive changes in reducing emissions across the entire business – whether that be in our efforts to minimise waste or reducing fuel consumption. Ensuring our footprint is kept at a minimum where possible is at the top of our agenda and we couldn’t be prouder that this has been recognised by an independent panel of respected industry experts within the pharmaceutical industry – a sector within which we have a long and proud history serving. “Ultimately, it’s about doing the right thing. The world is undergoing a rate of change which is incomparable to anything humankind has ever faced before and therefore all need to play their part if the collective goal of defeating the worsening climate crisis is to be achieved. A huge thanks must therefore go out to all team members across the Aramex network who have each played a part in helping the company make such incredible inroads in its own sustainability goals.”

    admin
    Slot gacor maxwin
    Slot88
    TOGEL ONLINE